 | • レポートコード：GIR-22F19651 • 出版社/出版日：GlobalInfoResearch / 2022年11月 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Systemic Aspergillosis and Systemic Candidasis Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社の最新の調査によると、世界の全身性アスペルギルス症及び全身性カンジダ症の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 全身性アスペルギルス症及び全身性カンジダ症市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次をカバーします。 ・ボリコナゾール、リポソームアムホテリシンB、全身経口アゾール、外用抗真菌剤、その他 アプリケーション別セグメントは次のように区分されます。 ・CPA、ABPA、消化器カンジダ症、泌尿生殖器カンジダ症、その他 世界の全身性アスペルギルス症及び全身性カンジダ症市場の主要な市場プレーヤーは以下のとおりです。 ・Novartis AG、Pfizer, Inc、Sanofi-Aventis、Merck & Co., Inc、Enzon Pharmaceuticals, Inc、Bayer AG、Astellas Pharma, Inc、GlaxoSmithKline plc、Abbott 地域別セグメントは次の地域・国をカバーします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、全身性アスペルギルス症及び全身性カンジダ症製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な全身性アスペルギルス症及び全身性カンジダ症メーカーの企業概要、2019年～2022年までの全身性アスペルギルス症及び全身性カンジダ症の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な全身性アスペルギルス症及び全身性カンジダ症メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別全身性アスペルギルス症及び全身性カンジダ症の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの全身性アスペルギルス症及び全身性カンジダ症のタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での全身性アスペルギルス症及び全身性カンジダ症市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および全身性アスペルギルス症及び全身性カンジダ症の産業チェーンを掲載しています。 ・第13、14、15章では、全身性アスペルギルス症及び全身性カンジダ症の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - 全身性アスペルギルス症及び全身性カンジダ症の概要 - タイプ別分析（2017年vs2021年vs2028年）：ボリコナゾール、リポソームアムホテリシンB、全身経口アゾール、外用抗真菌剤、その他 - アプリケーション別分析（2017年vs2021年vs2028年）：CPA、ABPA、消化器カンジダ症、泌尿生殖器カンジダ症、その他 - 世界の全身性アスペルギルス症及び全身性カンジダ症市場規模・予測 - 世界の全身性アスペルギルス症及び全身性カンジダ症生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Novartis AG、Pfizer, Inc、Sanofi-Aventis、Merck & Co., Inc、Enzon Pharmaceuticals, Inc、Bayer AG、Astellas Pharma, Inc、GlaxoSmithKline plc、Abbott ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：ボリコナゾール、リポソームアムホテリシンB、全身経口アゾール、外用抗真菌剤、その他 ・アプリケーション別分析2017年-2028年：CPA、ABPA、消化器カンジダ症、泌尿生殖器カンジダ症、その他 ・全身性アスペルギルス症及び全身性カンジダ症の北米市場分析 - 全身性アスペルギルス症及び全身性カンジダ症の北米市場：タイプ別市場規模2017年-2028年 - 全身性アスペルギルス症及び全身性カンジダ症の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・全身性アスペルギルス症及び全身性カンジダ症のヨーロッパ市場分析 - ：全身性アスペルギルス症及び全身性カンジダ症のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：全身性アスペルギルス症及び全身性カンジダ症のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・全身性アスペルギルス症及び全身性カンジダ症のアジア太平洋市場分析 - 全身性アスペルギルス症及び全身性カンジダ症のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 全身性アスペルギルス症及び全身性カンジダ症のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・全身性アスペルギルス症及び全身性カンジダ症の南米市場分析 - 全身性アスペルギルス症及び全身性カンジダ症の南米市場：タイプ別市場規模2017年-2028年 - 全身性アスペルギルス症及び全身性カンジダ症の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・全身性アスペルギルス症及び全身性カンジダ症の中東・アフリカ市場分析 - 全身性アスペルギルス症及び全身性カンジダ症の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 全身性アスペルギルス症及び全身性カンジダ症の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Systemic Aspergillosis and Systemic Candidasis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Systemic Aspergillosis and Systemic Candidasis market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. CPA accounting for % of the Systemic Aspergillosis and Systemic Candidasis global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Voriconazole segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Systemic Aspergillosis and Systemic Candidasis include Novartis AG, Pfizer, Inc, Sanofi-Aventis, Merck & Co., Inc, and Enzon Pharmaceuticals, Inc, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Systemic Aspergillosis and Systemic Candidasis market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Voriconazole
Liposomal Amphotericin B
Systemic Oral Azoles
Topical Antifungal Agents
Other
Market segment by Application can be divided into
CPA
ABPA
Gastrointestinal Candidiasis
Genitourinary Tract Candidiasis
Other
The key market players for global Systemic Aspergillosis and Systemic Candidasis market are listed below:
Novartis AG
Pfizer, Inc
Sanofi-Aventis
Merck & Co., Inc
Enzon Pharmaceuticals, Inc
Bayer AG
Astellas Pharma, Inc
GlaxoSmithKline plc
Abbott
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Systemic Aspergillosis and Systemic Candidasis product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Systemic Aspergillosis and Systemic Candidasis, with price, sales, revenue and global market share of Systemic Aspergillosis and Systemic Candidasis from 2019 to 2022.
Chapter 3, the Systemic Aspergillosis and Systemic Candidasis competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Systemic Aspergillosis and Systemic Candidasis breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Systemic Aspergillosis and Systemic Candidasis market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Systemic Aspergillosis and Systemic Candidasis.
Chapter 13, 14, and 15, to describe Systemic Aspergillosis and Systemic Candidasis sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Systemic Aspergillosis and Systemic Candidasis Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Systemic Aspergillosis and Systemic Candidasis Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Voriconazole
1.2.3 Liposomal Amphotericin B
1.2.4 Systemic Oral Azoles
1.2.5 Topical Antifungal Agents
1.2.6 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Systemic Aspergillosis and Systemic Candidasis Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 CPA
1.3.3 ABPA
1.3.4 Gastrointestinal Candidiasis
1.3.5 Genitourinary Tract Candidiasis
1.3.6 Other
1.4 Global Systemic Aspergillosis and Systemic Candidasis Market Size & Forecast
1.4.1 Global Systemic Aspergillosis and Systemic Candidasis Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Systemic Aspergillosis and Systemic Candidasis Sales in Volume (2017-2028)
1.4.3 Global Systemic Aspergillosis and Systemic Candidasis Price (2017-2028)
1.5 Global Systemic Aspergillosis and Systemic Candidasis Production Capacity Analysis
1.5.1 Global Systemic Aspergillosis and Systemic Candidasis Total Production Capacity (2017-2028)
1.5.2 Global Systemic Aspergillosis and Systemic Candidasis Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Systemic Aspergillosis and Systemic Candidasis Market Drivers
1.6.2 Systemic Aspergillosis and Systemic Candidasis Market Restraints
1.6.3 Systemic Aspergillosis and Systemic Candidasis Trends Analysis
2 Manufacturers Profiles
2.1 Novartis AG
2.1.1 Novartis AG Details
2.1.2 Novartis AG Major Business
2.1.3 Novartis AG Systemic Aspergillosis and Systemic Candidasis Product and Services
2.1.4 Novartis AG Systemic Aspergillosis and Systemic Candidasis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Pfizer, Inc
2.2.1 Pfizer, Inc Details
2.2.2 Pfizer, Inc Major Business
2.2.3 Pfizer, Inc Systemic Aspergillosis and Systemic Candidasis Product and Services
2.2.4 Pfizer, Inc Systemic Aspergillosis and Systemic Candidasis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Sanofi-Aventis
2.3.1 Sanofi-Aventis Details
2.3.2 Sanofi-Aventis Major Business
2.3.3 Sanofi-Aventis Systemic Aspergillosis and Systemic Candidasis Product and Services
2.3.4 Sanofi-Aventis Systemic Aspergillosis and Systemic Candidasis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Merck & Co., Inc
2.4.1 Merck & Co., Inc Details
2.4.2 Merck & Co., Inc Major Business
2.4.3 Merck & Co., Inc Systemic Aspergillosis and Systemic Candidasis Product and Services
2.4.4 Merck & Co., Inc Systemic Aspergillosis and Systemic Candidasis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Enzon Pharmaceuticals, Inc
2.5.1 Enzon Pharmaceuticals, Inc Details
2.5.2 Enzon Pharmaceuticals, Inc Major Business
2.5.3 Enzon Pharmaceuticals, Inc Systemic Aspergillosis and Systemic Candidasis Product and Services
2.5.4 Enzon Pharmaceuticals, Inc Systemic Aspergillosis and Systemic Candidasis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Bayer AG
2.6.1 Bayer AG Details
2.6.2 Bayer AG Major Business
2.6.3 Bayer AG Systemic Aspergillosis and Systemic Candidasis Product and Services
2.6.4 Bayer AG Systemic Aspergillosis and Systemic Candidasis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Astellas Pharma, Inc
2.7.1 Astellas Pharma, Inc Details
2.7.2 Astellas Pharma, Inc Major Business
2.7.3 Astellas Pharma, Inc Systemic Aspergillosis and Systemic Candidasis Product and Services
2.7.4 Astellas Pharma, Inc Systemic Aspergillosis and Systemic Candidasis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 GlaxoSmithKline plc
2.8.1 GlaxoSmithKline plc Details
2.8.2 GlaxoSmithKline plc Major Business
2.8.3 GlaxoSmithKline plc Systemic Aspergillosis and Systemic Candidasis Product and Services
2.8.4 GlaxoSmithKline plc Systemic Aspergillosis and Systemic Candidasis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Abbott
2.9.1 Abbott Details
2.9.2 Abbott Major Business
2.9.3 Abbott Systemic Aspergillosis and Systemic Candidasis Product and Services
2.9.4 Abbott Systemic Aspergillosis and Systemic Candidasis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Systemic Aspergillosis and Systemic Candidasis Breakdown Data by Manufacturer
3.1 Global Systemic Aspergillosis and Systemic Candidasis Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Systemic Aspergillosis and Systemic Candidasis Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Systemic Aspergillosis and Systemic Candidasis
3.4 Market Concentration Rate
3.4.1 Top 3 Systemic Aspergillosis and Systemic Candidasis Manufacturer Market Share in 2021
3.4.2 Top 6 Systemic Aspergillosis and Systemic Candidasis Manufacturer Market Share in 2021
3.5 Global Systemic Aspergillosis and Systemic Candidasis Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Systemic Aspergillosis and Systemic Candidasis Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Systemic Aspergillosis and Systemic Candidasis Market Size by Region
4.1.1 Global Systemic Aspergillosis and Systemic Candidasis Sales in Volume by Region (2017-2028)
4.1.2 Global Systemic Aspergillosis and Systemic Candidasis Revenue by Region (2017-2028)
4.2 North America Systemic Aspergillosis and Systemic Candidasis Revenue (2017-2028)
4.3 Europe Systemic Aspergillosis and Systemic Candidasis Revenue (2017-2028)
4.4 Asia-Pacific Systemic Aspergillosis and Systemic Candidasis Revenue (2017-2028)
4.5 South America Systemic Aspergillosis and Systemic Candidasis Revenue (2017-2028)
4.6 Middle East and Africa Systemic Aspergillosis and Systemic Candidasis Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Systemic Aspergillosis and Systemic Candidasis Sales in Volume by Type (2017-2028)
5.2 Global Systemic Aspergillosis and Systemic Candidasis Revenue by Type (2017-2028)
5.3 Global Systemic Aspergillosis and Systemic Candidasis Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Systemic Aspergillosis and Systemic Candidasis Sales in Volume by Application (2017-2028)
6.2 Global Systemic Aspergillosis and Systemic Candidasis Revenue by Application (2017-2028)
6.3 Global Systemic Aspergillosis and Systemic Candidasis Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Systemic Aspergillosis and Systemic Candidasis Sales by Type (2017-2028)
7.2 North America Systemic Aspergillosis and Systemic Candidasis Sales by Application (2017-2028)
7.3 North America Systemic Aspergillosis and Systemic Candidasis Market Size by Country
7.3.1 North America Systemic Aspergillosis and Systemic Candidasis Sales in Volume by Country (2017-2028)
7.3.2 North America Systemic Aspergillosis and Systemic Candidasis Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Systemic Aspergillosis and Systemic Candidasis Sales by Type (2017-2028)
8.2 Europe Systemic Aspergillosis and Systemic Candidasis Sales by Application (2017-2028)
8.3 Europe Systemic Aspergillosis and Systemic Candidasis Market Size by Country
8.3.1 Europe Systemic Aspergillosis and Systemic Candidasis Sales in Volume by Country (2017-2028)
8.3.2 Europe Systemic Aspergillosis and Systemic Candidasis Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Systemic Aspergillosis and Systemic Candidasis Sales by Type (2017-2028)
9.2 Asia-Pacific Systemic Aspergillosis and Systemic Candidasis Sales by Application (2017-2028)
9.3 Asia-Pacific Systemic Aspergillosis and Systemic Candidasis Market Size by Region
9.3.1 Asia-Pacific Systemic Aspergillosis and Systemic Candidasis Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Systemic Aspergillosis and Systemic Candidasis Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Systemic Aspergillosis and Systemic Candidasis Sales by Type (2017-2028)
10.2 South America Systemic Aspergillosis and Systemic Candidasis Sales by Application (2017-2028)
10.3 South America Systemic Aspergillosis and Systemic Candidasis Market Size by Country
10.3.1 South America Systemic Aspergillosis and Systemic Candidasis Sales in Volume by Country (2017-2028)
10.3.2 South America Systemic Aspergillosis and Systemic Candidasis Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Sales by Type (2017-2028)
11.2 Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Sales by Application (2017-2028)
11.3 Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Market Size by Country
11.3.1 Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Systemic Aspergillosis and Systemic Candidasis Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Systemic Aspergillosis and Systemic Candidasis and Key Manufacturers
12.2 Manufacturing Costs Percentage of Systemic Aspergillosis and Systemic Candidasis
12.3 Systemic Aspergillosis and Systemic Candidasis Production Process
12.4 Systemic Aspergillosis and Systemic Candidasis Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Systemic Aspergillosis and Systemic Candidasis Typical Distributors
13.3 Systemic Aspergillosis and Systemic Candidasis Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer